secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2026-06-16T20:00:58+00:00
Accession:  0001104659-26-074558
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion HSR waiting period cleared for ArchiMed merger; shareholder vote set for July 8
--------------------------------------------------------------------------------

- Hart-Scott-Rodino waiting period expired June 15, 2026, satisfying a key regulatory condition.
- Special stockholder meeting to vote on merger adoption scheduled for July 8, 2026 at 8:00 a.m. ET.
- Closing remains subject to other customary conditions, including stockholder approval.
- Merger with affiliate of ArchiMed SAS was announced May 1, 2026; transaction is pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465926074558/0001104659-26-074558-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465926074558/tm2617356d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074558

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer